Skip to main content
Clinical Trials/ISRCTN55509212
ISRCTN55509212
Completed
未知

A feasibility study for a multi-centre, randomised controlled trial evaluating the effects of early administration of cryoprecipitate in major traumatic haemorrhage.

HS Blood and Transplant Service (UK)0 sites40 target enrollmentSeptember 13, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
HS Blood and Transplant Service (UK)
Enrollment
40
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 13, 2012
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HS Blood and Transplant Service (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Written informed consent or agreement is obtained before any study related activity
  • 2\. The participant is judged to be 16 or above in UK and is affected by traumatic injury
  • 3\. The participant is deemed by the attending clinician to have ongoing active haemorrhage on admission
  • AND REQUIRES
  • 4\. Activation of the local major haemorrhage protocol for management of severe blood loss

Exclusion Criteria

  • 1\. The patient has been transferred from another hospital
  • 2\. The trauma team leader deems the patient inappropriate for the trial i.e. injuries deemed to be incompatible with life
  • 3\. More than 3 hours has elapsed from the time of injury

Outcomes

Primary Outcomes

Not specified

Similar Trials